Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Community support helps staff wellbeing at Bronglais
- Woman Charged After 20+ Dogs Found In Unsanitary Conditions: Ewing PD
- Proposed class-action lawsuit filed against Healthcare SC following Winnsboro factory fire
- Hailey Bieber Casually Bares Her Abs in a Plunging Workout Bra and $9,500 Diamond Earrings
- Entries open for the 2026 Fleet News Wellbeing Award
- Over 550,000 Ukrainians undergo Health Screening 40+
- Arizona’s Sen. Gallego criticizes Trump’s healthcare coverage cuts
- Chester fitness coach suffered stroke weeks after giving birth
Browsing: Weight Loss
One in four children overweight, Health Minister warns of obesity crisis – Trinidad Guardian Trinidad and Tobago Guardian Online Advertise With UsAbout UsListenWatch
More Medicare recipients are now eligible to get coverage for GLP-1 medications, like Ozempic, for weight loss under a new Bridge pilot program
— Phase 3 VANQUISH 1 & 2 Trials for Subcutaneous VK2735 in Obesity Fully Enrolled and Advancing —
Shareholders are suing Novo Nordisk over how the company talked up its next-generation obesity drug CagriSema. The core of the argument is that Novo gave investors one impression of the clinical trial – and the final results told a different story
Brazil’s national drug regulator approved five semaglutide injection pens simultaneously on Wednesday — the largest single-day batch of GLP-1 receptor agonist clearances any health agency has issued in the country’s history — yet none of the drugs can reach a pharmacy shelf until Brazil’s drug pricing chamber sets a price cap, a separate regulatory step…
Novo Nordisk must face part of a securities fraud lawsuit accusing the drugmaker of misleading investors about dosing and tolerability in a late-stage clinical trial for CagriSema, after a federal judge allowed a narrower set of shareholder claims to move forward
Demand for engineers with GLP-1 receptor agonist (RA) manufacturing skills is increasing as the market for the popular anti-obesity drugs continues to grow, according to Ireland’s NIBRT, which has set up a training course to help meet the need
WAGONER, Okla. — Take Off Pounds Sensibly (TOPS), a nonprofit weight loss organization, recognized a Wagoner woman for losing 92.5 pounds
Amgen (NASDAQ: AMGN) is betting that the convenience of its weight loss treatment will make it a winner, and it might be right. Its candidate MariTide is a monthly injection that aims to directly challenge the anti-obesity drugs made by Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), which in their original formulations are…
As interest in stimulant-free weight-management support grows in 2026, this AlkaSlim review examines the brand-stated four-ingredient formula, appetite and digestive-wellness positioning, current pricing, customer feedback, and the key details buyers are comparing before ordering

